Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction
by
Taguchi, Y-h.
, Turki, Turki
in
A549 Cells
/ Antibiotics
/ Antiviral agents
/ Antiviral Agents - chemistry
/ Antiviral Agents - classification
/ Antiviral Agents - pharmacology
/ Antiviral drugs
/ Atorvastatin
/ Betacoronavirus - drug effects
/ Biology and life sciences
/ Chelerythrine
/ Clinical trials
/ Coronaviridae
/ Coronaviruses
/ COVID-19
/ Decomposition
/ Doxycycline
/ Drug development
/ Drug discovery
/ Drug Discovery - methods
/ Drug therapy
/ Drugs
/ Feature extraction
/ Flavopiridol
/ Fluticasone
/ Gadolinium
/ Geldanamycin
/ Gene expression
/ Gentamicin
/ Humans
/ Infections
/ Inhibitor drugs
/ Innovations
/ Ivermectin
/ Lung cancer
/ Lung diseases
/ Mathematical analysis
/ Medicine and health sciences
/ Meloxicam
/ Methods
/ Mitoxantrone
/ Pandemics
/ Parasites
/ Pharmaceutical research
/ Proteins
/ Quercetin
/ SARS-CoV-2
/ Severe acute respiratory syndrome
/ Severe acute respiratory syndrome coronavirus 2
/ Targeted cancer therapy
/ Tensors
/ Trovafloxacin
/ Tumor cell lines
/ Unsupervised Machine Learning
/ Viral diseases
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction
by
Taguchi, Y-h.
, Turki, Turki
in
A549 Cells
/ Antibiotics
/ Antiviral agents
/ Antiviral Agents - chemistry
/ Antiviral Agents - classification
/ Antiviral Agents - pharmacology
/ Antiviral drugs
/ Atorvastatin
/ Betacoronavirus - drug effects
/ Biology and life sciences
/ Chelerythrine
/ Clinical trials
/ Coronaviridae
/ Coronaviruses
/ COVID-19
/ Decomposition
/ Doxycycline
/ Drug development
/ Drug discovery
/ Drug Discovery - methods
/ Drug therapy
/ Drugs
/ Feature extraction
/ Flavopiridol
/ Fluticasone
/ Gadolinium
/ Geldanamycin
/ Gene expression
/ Gentamicin
/ Humans
/ Infections
/ Inhibitor drugs
/ Innovations
/ Ivermectin
/ Lung cancer
/ Lung diseases
/ Mathematical analysis
/ Medicine and health sciences
/ Meloxicam
/ Methods
/ Mitoxantrone
/ Pandemics
/ Parasites
/ Pharmaceutical research
/ Proteins
/ Quercetin
/ SARS-CoV-2
/ Severe acute respiratory syndrome
/ Severe acute respiratory syndrome coronavirus 2
/ Targeted cancer therapy
/ Tensors
/ Trovafloxacin
/ Tumor cell lines
/ Unsupervised Machine Learning
/ Viral diseases
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction
by
Taguchi, Y-h.
, Turki, Turki
in
A549 Cells
/ Antibiotics
/ Antiviral agents
/ Antiviral Agents - chemistry
/ Antiviral Agents - classification
/ Antiviral Agents - pharmacology
/ Antiviral drugs
/ Atorvastatin
/ Betacoronavirus - drug effects
/ Biology and life sciences
/ Chelerythrine
/ Clinical trials
/ Coronaviridae
/ Coronaviruses
/ COVID-19
/ Decomposition
/ Doxycycline
/ Drug development
/ Drug discovery
/ Drug Discovery - methods
/ Drug therapy
/ Drugs
/ Feature extraction
/ Flavopiridol
/ Fluticasone
/ Gadolinium
/ Geldanamycin
/ Gene expression
/ Gentamicin
/ Humans
/ Infections
/ Inhibitor drugs
/ Innovations
/ Ivermectin
/ Lung cancer
/ Lung diseases
/ Mathematical analysis
/ Medicine and health sciences
/ Meloxicam
/ Methods
/ Mitoxantrone
/ Pandemics
/ Parasites
/ Pharmaceutical research
/ Proteins
/ Quercetin
/ SARS-CoV-2
/ Severe acute respiratory syndrome
/ Severe acute respiratory syndrome coronavirus 2
/ Targeted cancer therapy
/ Tensors
/ Trovafloxacin
/ Tumor cell lines
/ Unsupervised Machine Learning
/ Viral diseases
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction
Journal Article
A new advanced in silico drug discovery method for novel coronavirus (SARS-CoV-2) with tensor decomposition-based unsupervised feature extraction
2020
Request Book From Autostore
and Choose the Collection Method
Overview
COVID-19 is a critical pandemic that has affected human communities worldwide, and there is an urgent need to develop effective drugs. Although there are a large number of candidate drug compounds that may be useful for treating COVID-19, the evaluation of these drugs is time-consuming and costly. Thus, screening to identify potentially effective drugs prior to experimental validation is necessary.
In this study, we applied the recently proposed method tensor decomposition (TD)-based unsupervised feature extraction (FE) to gene expression profiles of multiple lung cancer cell lines infected with severe acute respiratory syndrome coronavirus 2. We identified drug candidate compounds that significantly altered the expression of the 163 genes selected by TD-based unsupervised FE.
Numerous drugs were successfully screened, including many known antiviral drug compounds such as C646, chelerythrine chloride, canertinib, BX-795, sorafenib, sorafenib, QL-X-138, radicicol, A-443654, CGP-60474, alvocidib, mitoxantrone, QL-XII-47, geldanamycin, fluticasone, atorvastatin, quercetin, motexafin gadolinium, trovafloxacin, doxycycline, meloxicam, gentamicin, and dibromochloromethane. The screen also identified ivermectin, which was first identified as an anti-parasite drug and recently the drug was included in clinical trials for SARS-CoV-2.
The drugs screened using our strategy may be effective candidates for treating patients with COVID-19.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Antiviral Agents - chemistry
/ Antiviral Agents - classification
/ Antiviral Agents - pharmacology
/ Betacoronavirus - drug effects
/ COVID-19
/ Drugs
/ Humans
/ Medicine and health sciences
/ Methods
/ Proteins
/ Severe acute respiratory syndrome
/ Severe acute respiratory syndrome coronavirus 2
/ Tensors
This website uses cookies to ensure you get the best experience on our website.